World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease
Çharles N. Bernstein(University of Toronto), Anton LeMair(University Malaya Medical Centre), Abraham R. Eliakim(Sheba Medical Center), Richard B. Gearry(New Leaders), Siew C. Ng(Chinese University of Hong Kong), Qin Ouyang(Army Medical University), И. Л. Халиф(University of Sussex), Khean‐Lee Goh(University of Malaya), Flávio Steinwurz(Hospital Israelita Albert Einstein), Jean‐François Rey(World Allergy Organization), Ajit Sood(Dayanand Medical College & Hospital), Aamir Khan(University of Iowa), S S Fedail(University of Khartoum), Saeed Hamid(Aga Khan University), Michael Fried(University Hospital of Zurich), Gillian Watermeyer
Cited by 232
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.7k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k